|
1
|
Roger VL, Go AS, Lloyd-Jones DM, Benjamin
EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al:
Executive summary: Heart disease and stroke statistics-2012 update:
A report from the American Heart Association. Circulation.
125:188–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reed GW, Rossi JE and Cannon CP: Acute
myocardial infarction. Lancet. 389:197–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
White HD, Thygesen K, Alpert JS and Jaffe
AS: Clinical implications of the third universal definition of
myocardial infarction. Heart. 100:424–432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schüssler-Lenz M, Beuneu C,
Menezes-Ferreira M, Jekerle V, Bartunek J, Chamuleau S, Celis P,
Doevendans P, O'Donovan M, Hill J, et al: Cell-based therapies for
cardiac repair: A meeting report on scientific observations crud
European regulatory viewpoints. Eur J Heart Fail. 18:133–141. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frangogiannis NG: Regulation of the
inflammatory response in cardiac repair. Circ Res. 110:159–173.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng Y, Zhao J, Hou H, Zhang H, Jiao Y,
Wang J, Wang Y and Sun Y: WDR26 promotes mitophagy of
cardiomyocytes induced by hypoxia through Parkin translocation.
Acta Biochim Biophys Sin (Shanghai). 48:1075–1084. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Swynghedauw B: Molecular mechanisms of
myocardial remodeling. Physiol Rev. 79:215–262. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Minicucci MF, Azevedo PS, Polegato BF,
Paiva SA and Zornoff LA: Heart failure after myocardial infarction:
Clinical implications and treatment. Clin Cardiol. 34:410–414.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Whelan RS, Kaplinskiy V and Kitsis RN:
Cell death in the pathogenesis of heart disease: Mechanisms and
significance. Annu Rev Physiol. 72:19–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goretti E, Wagner DR and Devaux Y: miRNAs
as biomarkers of myocardial a step forward towards personalized
medicine? Trends Mol Med. 20:716–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fathil MF, Md Arshad MK, Gopinath SC,
Hashim U, Adzhri R, Ayub RM, Ruslinda AR, Nuzaihan MNM, Azman AH,
Zaki M and Tang TH: Diagnostics on acute myocardial infarction:
Cardiac troponin biomarkers. Biosens Bioelectron. 70:209–220. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim J, Yao F, Xiao Z, Sun Y and Ma L:
MicroRNAs and metastasis: Small RNAs play big roles. Cancer
Metastasis Rev. 37:5–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res 39 (Database Issue). D152–D157. 2011. View Article : Google Scholar
|
|
15
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujii T, Shimada K, Nakai T and Ohbayashi
C: MicroRNAs in smoking-related carcinogenesis: Biomarkers,
functions, and therapy. J Clin Med. 7(pii): E982018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu X and Li H: Integrated microRNA-gene
analysis of coronary artery disease based on miRNA and gene
expression profiles. Mol Med Rep. 13:3063–3073. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harada M, Luo X, Murohara T, Yang B,
Dobrev D and Nattel S: MicroRNA regulation and cardiac calcium
signaling: Role in cardiac disease and therapeutic potential. Circ
Res. 114:689–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matkovich SJ and Hu Y: Regulation of
cardiac microRNAs by cardiac microRNAs. Circ Res. 113:62–71. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Z, Li C, Lin K, Zhang Q, Chen Y and
Rao L: MicroRNAs in acute myocardial infarction: Evident value as
novel biomarkers? Anatol J Cardiol. 19:140–147. 2018.PubMed/NCBI
|
|
21
|
Paiva S and Agbulut O: MiRroring the
multiple potentials of MicroRNAs in acute myocardial infarction.
Front Cardiovasc Med. 4:732017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo ML, Guo LL and Weng YQ: Implication of
peripheral blood miRNA-124 in predicting acute myocardial
infarction. Eur Rev Med Pharmacol Sci. 21:1054–1059.
2017.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dreikhausen U, Hiebenthal-Millow K,
Bartels M, Resch K and Nourbakhsh M: NF-kappaB-repressing factor
inhibits elongation of human immunodeficiency virus type 1
transcription by DRB sensitivity-inducing factor. Mol Cell Biol.
25:7473–7483. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
White HD and Chew DP: Acute myocardial
infarction. Lancet. 372:570–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Heart disease and stroke statistics-2014 update: A report from the
American Heart Association. Circulation. 129:e28–e292. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kulkarni S, Qi Y, O'HUigin C, Pereyra F,
Ramsuran V, McLaren P, Fellay J, Nelson G, Chen H, Liao W, et al:
Genetic interplay between HLA-C and MIR148A in HIV control and
Crohn disease. Proc Natl Acad Sci USA. 110:20705–20710. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Finn NA and Searles CD: Intracellular and
extracellular miRNAs in regulation of angiogenesis signaling. Curr
Angiogenes. 4:299–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang YY, Li T, Liu YW, Wang Y, Hu XM, Gao
WQ, Wu P, Li X, Peng WJ, Gao W, et al: Ischemic postconditioning
before percutaneous coronary intervention for acute ST-segment
elevation myocardial infarction reduces contrast-induced
nephropathy and improves long-term prognosis. Arch Med Res.
47:483–488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Marchant DJ, Boyd JH, Lin DC, Granville
DJ, Garmaroudi FS and McManus BM: Infammation in myocardial
diseases. Circ Res. 110:126–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He Q, Zhou W, Xiong C, Tan G and Chen M:
Lycopene attenuates inflammation and apoptosis in post-myocardial
infarction remodeling by inhibiting the nuclear factor-κB signaling
pathway. Mol Med Rep. 11:374–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng P, Zeng W, Li L, Huo D, Zeng L, Tan
J, Zhou J, Sun J, Liu G, Li Y, et al: PLGA-PNIPAM microspheres
loaded with the gastrointestinal nutrient NaB ameliorate cardiac
dysfunction by activating Sirt3 in acute myocardial infarction. Adv
Sci (Weinh). 3:16002542016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Santana ET, Feliciano RD, Serra AJ,
Brigidio E, Antonio EL, Tucci PJ, Nathanson L, Morris M and Silva
JA Jr: Comparative mRNA and MicroRNA profling during acute
myocardial infarction induced by coronary occlusion and ablation
radio-frequency currents. Front Physiol. 7:5652016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Geng L, Liu W and Chen Y: miR-124-3p
attenuates MPP+-induced neuronal injury by targeting
STAT3 in SH-SY5Y cells. Exp Biol Med (Maywood). 242:1757–1764.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan Q, Sun T, Ye F, Kong W and Jin H:
MicroRNA-124-3p affects proliferation, migration and apoptosis of
bladder cancer cells through targeting AURKA. Cancer Biomark.
19:93–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kang Q, Xiang Y, Li D, Liang J, Zhang X,
Zhou F, Qiao M, Nie Y, He Y, Cheng J, et al: miR-124-3p attenuates
hyperphosphorylation of Tau protein-induced apoptosis via
caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells.
Oncotarget. 8:24314–24326. 2017.PubMed/NCBI
|
|
37
|
Dong RF, Zhang B, Tai LW, Liu HM, Shi FK
and Liu NN: The neuroprotective role of miR-124-3p in a
6-hydroxydopamine-induced cell model of parkinson's disease via the
regulation of ANAX5. J Cell Biochem. 119:269–277. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang S, Ge X, Yu J, Han Z, Yin Z, Li Y,
Chen F, Wang H, Zhang J and Lei P: Increased miR-124-3p in
microglial exosomes following traumatic brain injury inhibits
neuronal inflammation and contributes to neurite outgrowth via
their transfer into neurons. FASEB J. 32:512–528. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang N, Xia J, Jiang B, Xu Y and Li Y:
TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells.
Biomed Pharmacother. 103:1669–1677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nourbakhsh M and Hauser H: The
transcriptional silencer protein NRF: A repressor of NF-kappa B
enhancers. Immunobiology. 198:65–72. 1997. View Article : Google Scholar : PubMed/NCBI
|
